- 1. *Pressure (Partial)
- (UMLS (HL7) C0030604) =Natural Phenomenon or Process ;
=Kind of quantity;
| - 51. prairie dog
- [ ] (UMLS (CSP) C0032898) =Mammal
|
- 2. 1,2,3-Propanetricarboxylic Acid, 2-hydroxy-, Gallium-(sup 67)Ga(1:1) Salt
- [A radioactive salt of gallium used as a radiopharmaceutical. The exact mechanism of action is unknown, but gallium citrate Ga-67 has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of inflammation. Adequate blood supply is essential for delivery of gallium citrate Ga-67 to the lesion. Gallium citrate Ga-67 is used as a diagnostic tool in neoplastic disease and inflammatory lesions. (NCI05) ( NCI )] (UMLS (NCI) C0893383) Gallium 67 citrate;
Gallium Citrate Ga-67;
GALLIUM CITRATE, GA-67;
GALLIUM CITRATE,GA-67;
GALLIUM CITRATE,GA-67 PREPARATION =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical =gallium citrate;
[DX201] IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS =GALLIUM CITRATE,GA-67 2 MIL;
| - 52. Prairie Island Indian Community of Minnesota Mdewa
- (UMLS (HL7) C1554426) =Population Group =NativeEntityContiguous;
|
- 3. 1,2,3-Propanetriol
- [1,2,3-trihydroxypropane, a key intermediate in glucose metabolism; also serves as the bridge between hydrophobic "tails" and hydrophilic "heads" of many membrane lipids; reagent is used as a water-soluble solvent and lubricant. ( CSP )] (UMLS (NCI) C0017861) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =[DE350] EMOLLIENTS;
sugar alcohol;
triose;
[OP106] OSMOTIC AGENTS, SYSTEMIC OPHTHALMIC;
[RS300] LAXATIVES, RECTAL;
[OP500] EYE WASHES/LUBRICANTS;
[OP900] OPHTHALMICS, OTHER;
=glyceryl trinitrate;
GLYCEROL,IODINATED;
thioglycerol;
GREEN SOAP;
AQUANIL LOTION;
MOISTUREL CREAM,TOP;
MOISTUREL More… | - 53. Pralidoxime Chloride
- (UMLS (NCI) C0139449) =Organic Chemical; Pharmacologic Substance =2 PAM;
=PRALIDOXIME CHLORIDE 1 GM/20ML |
- 4. 1,2,3-Propanetriyl Butanoate
- [A triglyceride drug that may inhibit cell growth and induce cell differentiation. Differentiating agents may be effective in changing cancer cells back into normal cells. ( NCI )] (UMLS (NCI) C0077025) =Lipid; Pharmacologic Substance ;
| - 54. Pramipexole Dihydrochloride
- [The hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and substantia nigra of the brain. Compared to other dopamine agonists, the use of this agent may be associated with fewer dyskinetic side effects in treated subjects. (NCI04) ( NCI )] (UMLS (NCI) C0772054) PRAMIPEXOLE DIHYDROCHLORIDE PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=pramipexol;
=PRAMIPEXOLE DIHYDROCHLORIDE 0.125 MG;
PRAMIPEXOLE DIHYDROCHLORIDE 0.25 MG;
PRAMIPEXOLE DIHYDROCHLORIDE 0.5 MG;
PRAMIPEXOLE DIHYDROCHLORIDE 1.5 MG;
PRAMIPEXOLE DIHYDROCHLORIDE 1 MG;
|
- 5. 1,2-Propyleneimine
- [A synthetic, flammable, volatile, colorless oily liquid that is soluble in water, ethanol and most organic solvents. Propylenimine is used in the United States exclusively as an intermediate, and its derivatives are used in the paper, textile, rubber and pharmaceutical industries. Due to its volatility, potential exposure could occur during production, packaging, or use of substances made with this liquid. The primary routes of potential human exposure to propylenimine are inhalation, ingestion and dermal contact. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0072231) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 55. PRAMLINTIDE
- (UMLS (NCI) C0537551) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 6. 1,3-Propanediol, 2-((3-fluoranthenylmethyl)amino)-2-methyl-
- (UMLS (NCI) C0100007) =Organic Chemical; Pharmacologic Substance ;
| - 56. Pramlintide Acetate
- (UMLS (NCI) C1174779) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 7. 1,3-Propanediol, 2-Amino-2-(hydroxymethyl)-
- [A member of the pyrrolo-pyrrole group of non-steroidal anti-inflammatory drugs (NSAID) with analgesic, anti-inflammatory, and anti-pyretic properties. Tromethamine inhibits both isoforms of cyclooxygenases (COX1 and COX2), thereby blocking the conversion of arachidonic acid to pro-inflammatory pro-prostaglandins. When inhibiting COX2, tromethamine may be effective in relieving pain and inflammation; when inhibiting COX1, this agent may produce unacceptable gastrointestinal side effects. ( NCI )] (UMLS (NCI) C0041175) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =propanediol;
[TN900] THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYTES, OTHER =Lodoxamide Tromethamine;
(1R,2S)-(1,2-Epoxypropyl)phosphonic Acid, compound with 2-Amino-2-(hydroxymethyl)-1,3-propanediol(1:1);
TEST;
TROMETHAMINE 18 GM;
TROMETHAMINE 36 GM;
TROMETHAMINE 1.2 MG;
TROMETHAMINE 1.21 MG/ML;
TROMETHAMINE 83 MCG/ML;
| - 57. pravachol
- [ ] (UMLS (CSP) C0700763) =Organic Chemical; Pharmacologic Substance
|
- 8. 1,3-Propanediol, 2-methyl-2-propyl-, Dicarbamate
- [A carbamate derivate with hypnotic, anti-anxiety, sedative, anticonvulsant and some indirect muscle relaxant properties. Although the exact mechanism of meprobamate is largely unknown, it appears to act as a depressant at multiple sites in the central nervous system, mostly likely through the GABAergic neurotransmitter system, including the thalamus and limbic system. ( NCI )] (UMLS (NCI) C0025386) =Organic Chemical; Pharmacologic Substance ;
=carbamate;
[CN309] SEDATIVES/HYPNOTICS, OTHER =MEPROBAMATE 200 MG;
MEPROBAMATE 400 MG;
MEPROBAMATE 600 MG;
| - 58. Praxis Biologics
- (UMLS (HL7) C1546891) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
|
- 9. 1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate
- [A synthetic glucocorticoid receptor agonist that mimics the metabolic, anti-inflammatory, and immunosuppressive activity of the natural glucocorticoids. Amcinonide interacts with specific corticosteroid receptors and was internalized, which leads to binding of DNA and modification of gene expression. This results in synthesis of anti-inflammatory mediators while inhibiting synthesis of inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are achieved. ( NCI )] (UMLS (NCI) C0051556) =Steroid; Pharmacologic Substance =(11beta,16alpha)-9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione;
[DE200] ANTI-INFLAMMATORY, TOPICAL =AMCINONIDE 0.1 % | - 59. Praxis Biologics [Inactive - use WAL]
- [Praxis Biologics [Inactive-use WAL] ( HL7V3.0 )] (UMLS (HL7) C1552901) =Health Care Related Organization ;
=VaccineManufacturer;
|
- 10. 1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, Chloride
- [The chloride salt form of methacholine, a direct-acting cholinergic muscarinic agonist with bronchoconstrictive, miotic, vasodilator, and cardiac vagomimetic activity. Methacholine chloride acts directly on the muscarinic receptors in the heart, eye, and lung, thereby producing parasympathomimetic effects. ( NCI )] (UMLS (NCI) C0079829) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =Methacholine Compounds;
METHACHOLINE =METHACHOLINE CHLORIDE 100 MG;
METHACHOLINE CHLORIDE 20 MG/ML;
METHACHOLINE CHLORIDE 0.25 %;
| - 60. prayer therapy
- [ ] (UMLS (CSP) C0597810) =Therapeutic or Preventive Procedure
|
- 11. 1-Propanol, 3,3'-, dimethanesulfonate (ester), hydrochloride
- (UMLS (NCI) C0971903) 1-Propanol, 3,3'-Iminobis-, Dimethanesulfonate (Ester), Hydrochloride (9CI;
1-Propanol, 3,3'-iminobis-, dimethanesulfonate (ester), hydrochloride (9CI);
1-Propanol, 3,3'-iminodi-, dimethanesulfonate (ester), hydrochloride (8CI);
1-Propanol-3,3'-iminodidimethanesulfonatehydrochloride;
3, 3'-Dimesyloxydipropylamine HCl;
3, 3'-Dimesyloxydipropylamine hydrochloride;
3, 3'-Iminodi-1-propanol Di(methanesulfonate) HCl;
3, 3'-Iminodi-1-propanol di(methanesulfonate) hydrochloride;
3, 3'-Iminodi-1-propanol Dimethanesulfonate Ester HCl;
3, 3'-Iminodi-1-propanol dimethanesulfonate ester hydrochloride;
3,3'-Imidodi-1-propanol, Dimethanesulfonate (Ester) HCl;
3,3'-Imidodi-1-propanol, dimethanesulfonate (ester), hydrochloride;
Bis(3-mesyloxypropyl)amine HCl;
Bis(3-mesyloxypropyl)amine hydrochloride;
IPD hydrochloride =Organic Chemical; Pharmacologic Substance ;
| - 61. PRAZEPAM
- [A benzodiazepine that is used in the treatment of ANXIETY DISORDERS. ( MSH )] (UMLS (NCI) C0032910) =Organic Chemical; Pharmacologic Substance ;
=Benzodiazepinones;
[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS |
- 12. 1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, Hydrochloride
- [The hydrochloride salt form of propafenone with class 1C antiarrhythmic effects. Propafenone hydrochloride stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby reducing sodium influx required for the initiation and conduction of impulses in Purkinje and myocardial cells. This agent produces a marked depression of phase 0 and prolonged effective refractory period in the atrio-ventricular nodal and His-Purkinje tissue, resulting in a profound decrease in excitability, conduction velocity and automaticity, thereby counteracting atrial and ventricular arrythmias. ( NCI )] (UMLS (NCI) C0700465) =Organic Chemical; Pharmacologic Substance =PROPAFENONE;
=PROPAFENONE HYDROCHLORIDE 150 MG;
PROPAFENONE HYDROCHLORIDE 225 MG;
PROPAFENONE HYDROCHLORIDE 300 MG | - 62. PRBLM RLTD LFSTYLE NOS
- [ ] (UMLS (ICD9CM) C0348775) =Finding
|
- 13. 1-Propanone, 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-
- [A substance that is used to treat depression, and to help people quit smoking. It belongs to the family of drugs called antidepressants. ( NCI )] (UMLS (NCI) C0085208) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
Propiophenones;
[CN609] ANTIDEPRESSANTS, OTHER;
=(+-)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone Hydrochloride;
BUPROPION 150 MG;
BUPROPION 200 MG;
BUPROPION 300 MG;
| - 63. PRDL/TMX
- (UMLS (NCI) C0279341) =Therapeutic or Preventive Procedure
|
- 14. 1-Propanone, 2-methyl-1,2-di-3-pyridinyl-
- [USP lists as a diagnostc aid for determination of pituitary function. ( CSP )] (UMLS (NCI) C0025876) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =pyridine;
ACTH inhibitor;
[DX900] DIAGNOSTICS, OTHER;
=METYRAPONE 250 MG | - 64. PRDL/VCR
- (UMLS (NCI) C0078413) =Therapeutic or Preventive Procedure
|
- 15. 1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-
- [The hydrochloride salt of Dyclonine, an unclassified compound with local anesthetic effect. Dyclonine reversibly binds to activated sodium channels on the neuronal membrane, thereby decreasing the neuronal membrane's permeability to sodium ions, leading to an increased threshold for excitation. This reversibly stabilizes the membrane and inhibits depolarization, leading to the failure of a propagated action potential and subsequent conduction blockade. This results in a transient and reversible loss of sensation in a localized area of the body. ( NCI )] (UMLS (NCI) C0058831) =Organic Chemical; Pharmacologic Substance =Propiophenones;
[DE700] LOCAL ANESTHETICS, TOPICAL =1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride;
| - 65. pre mRNA
- [newly transcribed RNA fully complementary to the DNA sequence of structural genes; this component of the spliceosome and hnRNA is spliced, 5' capped, 3' polyadenylated, transported to the cytoplasm as mature mRNA, and translated. ( CSP )] (UMLS (CSP) C0026661) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =heterogeneous nuclear RNA;
spliceosome |
- 16. 1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride
- [The hydrochloride salt of Dyclonine, an unclassified compound with local anesthetic effect. Dyclonine reversibly binds to activated sodium channels on the neuronal membrane, thereby decreasing the neuronal membrane's permeability to sodium ions, leading to an increased threshold for excitation. This reversibly stabilizes the membrane and inhibits depolarization, leading to the failure of a propagated action potential and subsequent conduction blockade. This results in a transient and reversible loss of sensation in a localized area of the body. ( NCI )] (UMLS (NCI) C0304455) =Organic Chemical; Pharmacologic Substance =1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-;
=DYCLONINE HYDROCHLORIDE 0.5 %;
DYCLONINE HYDROCHLORIDE 1 %;
DYCLONINE HYDROCHLORIDE 01 % | - 66. Pre-Admit Test Indicator
- (UMLS (HL7) C1550372) =Qualitative Concept =HL7 Vocabulary Version 2.5;
|
- 17. 10-(2-Propynyl)estr-4-ene-3,17-dione
- (UMLS (NCI) C0044695) =Steroid; Pharmacologic Substance ;
| - 67. Pre-authenticated
- [A completion status in which a document is transcribed but not authenticated. ( HL7V3.0 )] (UMLS (HL7) C1548389) =Idea or Concept =Document completion status;
DocumentCompletion |
- 18. 10-Propargyl-10-Deazaaminopterin
- [A substance that is being studied as an anticancer drug. It belongs to the family of drugs called folate analogues. ( NCI )] (UMLS (NCI) C0879404) PDX =Organic Chemical; Pharmacologic Substance ;
| - 68. Pre-B Acute Lymphoblastic Leukemia
- (UMLS (NCI) C1292769) =Neoplastic Process
|
- 19. 14-3-3 Protein Tau
- [Encoded by human YWHAQ Gene, 245-amino acid 27.8 kD YWHAQ Protein is a cytoplasmic homodimeric 14-3-3 family protein. 14-3-3 proteins are localized in neurons, and are axonally transported to the nerve terminals. 14-3-3 proteins may be present in other tissues as well. A probable multifunctional regulator of cell signaling processes, YWHAQ Protein strongly activates PKC and activates tyrosine and tryptophan hydroxylases in the presence of Ca(2+)/calmodulin-dependent protein kinase II. (Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1458135) 14-3-3 Protein T-Cell;
14-3-3 Protein Theta;
HS1 Protein;
Tyrosine 3/Tryptophan 5 -Monooxygenase Activation Protein, Theta Polypeptide;
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein, Theta Polypeptide;
YWHAQ;
YWHAQ Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 69. Pre-B Lymphocyte
- [Cells from the stage of B LYMPHOCYTE development where B CELL HEAVY CHAIN GENE REARRANGEMENT is completed. The pre-B cell stage is preceded by the pro-B cell stage. ( MSH )] (UMLS (NCI) C0312738) =Cell ;
|
- 20. 2 propylvalerate
- [fatty acid with anticonvulsant properties. ( CSP )] (UMLS (CSP) C0080356) =Lipid; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
2-Propylpentanoic Acid;
carboxylate;
=2-Propylpentanoic Acid Sodium Salt;
| - 70. Pre-Dilution
- [The dilution of the specimen made prior to being loaded onto analytical equipment ( HL7V3.0 )] (UMLS (HL7) C1551349) =Idea or Concept =ActSpecObsDilutionCode;
|
- 21. 2-(Propylamino)-o-propionotoluidide Hydrochloride
- [The hydrochloride salt form of prilocaine, an intermediate-acting local anesthetic of the amide type chemically related to lidocaine. Prilocaine hydrochloride binds to voltage-gated sodium ion channels in the neuronal membrane, thereby preventing the permeability of sodium ions. This leads to a stabilization of the neuronal membrane and inhibits depolarization and results in a reversible blockage of nerve impulse generation and propagation along nerve fibres and subsequent reversible loss of sensation. ( NCI )] (UMLS (NCI) C0008846) =Organic Chemical; Pharmacologic Substance =6,7-Epoxytropine Tropate;
=PRILOCAINE HYDROCHLORIDE 4 %;
| - 71. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension
- [ ] (UMLS (ICD9CM) C0156679) =Disease or Syndrome
|
- 22. 2-Propanol-1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy) Hydrochloride
- [The hydrochloride form of propranolol, a synthetic beta-adrenergic receptor blocker with antianginal, antiarrhythmic, antihypertensive properties. Propranolol competitively antagonizes beta-adrenergic receptors, thereby inhibiting beta-adrenergic reactions, such as vasodilation, and negative chronotropic and inotropic effects. ( NCI )] (UMLS (NCI) C0282321) =Organic Chemical; Pharmacologic Substance ;
=1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol;
=PROPRANOLOL HYDROCHLORIDE 60 MG;
PROPRANOLOL HYDROCHLORIDE 80 MG;
PROPRANOLOL HYDROCHLORIDE 120 MG;
PROPRANOLOL HYDROCHLORIDE 160 MG;
PROPRANOLOL HYDROCHLORIDE 80 MG/ML;
PROPRANOLOL HYDROCHLORIDE 1 MG/ML;
PROPRANOLOL HYDROCHLORIDE 20 MG/5ML;
PROPRANOLOL HYDROCHLORIDE 40 MG/5ML;
PROPRANOLOL HYDROCHLORIDE 10 MG;
PROPRANOLOL HYDROCHLORIDE 40 MG;
PROPRANOLOL HYDROCHLORIDE 20 MG;
PROPRANOLOL HYDROCHLORIDE 90 MG | - 72. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, antepartum
- [ ] (UMLS (ICD9CM) C0156683) =Disease or Syndrome
|
- 23. 2-Propanone
- [colorless liquid used as a solvent and an antiseptic; one of the ketone bodies produced during ketoacidosis. ( CSP )] (UMLS (NCI) C0001002) =Organic Chemical; Pharmacologic Substance ;
| - 73. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, complicating pregnancy, childbirth, or the puerperium, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156680) =Disease or Syndrome
|
- 24. 2-Propenamide
- [colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile; primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries. ( CSP )] (UMLS (NCI) C0050587) =Organic Chemical; Hazardous or Poisonous Substance ;
=amide;
=polyacrylamide;
| - 74. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, postpartum
- [ ] (UMLS (ICD9CM) C0156684) =Disease or Syndrome
|
- 25. 2-Propenenitrile
- [AK-rih-low-NYE-tril A substance used to make plastics, rubber, and textiles. Exposure to acrylonitrile may increase the risk of developing certain cancers (such as lung, brain, or prostate cancer). ( NCI )] (UMLS (NCI) C0001223) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 75. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, with delivery
- [ ] (UMLS (ICD9CM) C0156681) =Disease or Syndrome
|
- 26. 2-Propylpentanoic Acid
- [A stable coordination compound comprised of sodium valproate and valproic acid with anticonvulsant and antiepileptic activities. Divalproex dissociates to the valproate ion in the gastrointestinal tract. This agent binds to and inhibits gamma-aminobutyric acid (GABA) transaminase and its anticonvulsant activity may be exerted by increasing brain concentration of GABA and by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings. Divalproex may also work by suppressing repetitive neuronal firing through inhibition of voltage-sensitive sodium channels. ( NCI )] (UMLS (NCI) C0042291) =Lipid; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
Pentanoic Acids;
2-Propylpentanoic Acid;
=2-Propylpentanoic Acid;
2 propylvalerate;
DIVALPROEX SODIUM;
VALPROIC ACID 250 MG;
VALPROIC ACID 250 MG/5ML | - 76. Pre-eclampsia or eclampsia superimposed on pre-existing hypertension, with delivery, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0156682) =Disease or Syndrome
|
- 27. 2-Propylpentanoic Acid Sodium Salt
- [The sodium salt form of valproic acid with anti-epileptic activity. Valproate sodium is converted into its active form, valproate ion, in blood. Although the mechanism of action remains to be elucidated, valproate sodium increases concentrations of gamma-aminobutyric acid (GABA) in the brain, probably due to inhibition of the enzymes responsible for the catabolism of GABA. This potentiates the synaptic actions of GABA. Valproate sodium may also affect potassium channels, thereby creating a direct membrane-stabilizing effect. ( NCI )] (UMLS (NCI) C0037567) =Lipid; Pharmacologic Substance ;
=2 propylvalerate;
=Sodium Valproate 100 MG/ML | - 77. Pre-Malignant Skin Epithelial Lesion
- (UMLS (NCI) C1335463) =Neoplastic Process ;
|
- 28. 2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic Acid
- (UMLS (NCI) C0298617) =Organic Chemical; Pharmacologic Substance
| - 78. pre-miRNA
- [Precursors to miRNA generated from pri-miRNA. They are exported from the nucleus where they are further processed by Dicer RNase to generate mature miRNA. ( MSH )] (UMLS (NCI) C1337053) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
|
- 29. 3 Prime Repair Exonuclease 1
- [TREX1 protein is phosphorylated by Ataxia Telangiectasia and Rad3 Related Protein (ATR), regulates ATR expression, and is an essential component of the DNA damage checkpoint pathway. TREX1 and ATR are mutually dependent partners in cell cycle checkpoint signaling pathways. The downstream ORF encodes isozymes that contain 3-prime-to-5-prime exonuclease activity and the excision of nucleotides from DNA 3-prime termini are required by DNA replication, repair, and recombination. They remove mismatched, modified, fragmented, and normal nucleotides to generate the appropriate 3-prime termini for subsequent steps in the DNA metabolic pathways. (NCI) ( NCI )] (UMLS (NCI) C0967200) ATR Interacting Protein;
ATR-Interacting Protein;
ATRIP;
Deoxyribonuclease III, DnaQ/MutD (E. coli)-Like;
DKFZp434J0310;
DNase III;
DRN3;
FLJ12343;
Three Prime Repair Exonuclease 1;
TREX1;
=Amino Acid, Peptide, or Protein; Enzyme ;
| - 79. Pre-Par
- (UMLS (NCI) C0043440) =Organic Chemical; Pharmacologic Substance
|
- 30. 6-Propyl-2-thiouracil
- [A thiourea derivative with antithyroid property. Propylthiouracil (PTU) interferes with the oxidation of iodine possibly by interaction with peroxidase or a peroxidase-mediated complex reaction, thereby inhibiting synthesis of thyroid hormones tri-iodothyronine (T3) and thyroxine (T4). In addition, this agent inhibits the Type I 5'-deiodinase (D1), an enzyme involved in the peripheral conversion of thyroxine to tri-iodothyronine. This results in decreased plasma triodothyronine concentrations and decreased entrance of thyroxine into cells thereby reducing thyroid hormone activity. ( NCI )] (UMLS (NCI) C0033511) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =thiouracil;
[HS852] ANTITHYROID AGENTS =PROPYLTHIOURACIL 50 MG;
| - 80. pre-RC
- [The Origin Recognition Complex (ORC) in eukaryotic cells selects genomic sites where pre-replication complexes (pre-RCs) can be assembled. Subsequent activation of these pre-RCs results in bi-directional DNA replication that originates at or close to the ORC DNA binding sites. (From PubMed 12801628) ( NCI )] (UMLS (NCI) C1335464) Pre-Replication Complex =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 31. P105-RB
- [nuclear protein product of the Rb gene; regulated by phosphorylation; inhibits cell cycle progression in its dephosphorylated form. ( CSP )] (UMLS (NCI) C0080113) =Amino Acid, Peptide, or Protein; Biologically Active Substance =nuclear protein;
Phosphoprotein;
Tumor Suppressor Protein;
| - 81. preadmission counseling
- [counseling given to individuals being admitted to the hospital to prepare them for the visit. ( CSP )] (UMLS (CSP) C0597278) =Health Care Activity ;
=counseling;
preadmission patient care |
- 32. p160ROCK
- [Encoded by human ROCK1 Gene, Rho-Associated Coiled-Coil Containing Protein Kinase 1 is a Ser/Thr kinase activated when bound to GTP-bound Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between inactive GDP-bound and active GTP-bound forms. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. As a downstream effector of Rho, ROCK phosphorylates and activates LIM kinase, which phosphorylates cofilin and inhibits its actin-depolymerizing activity. (NCI) ( NCI )] (UMLS (NCI) C1335632) Rho-Associated, Coiled-Coil Containing Protein Kinase 1;
ROCK1 =Amino Acid, Peptide, or Protein; Enzyme | - 82. preadmission patient care
- [services or procedures, such as laboratory tests and x-rays, performed on individuals being admitted to the hospital. ( CSP )] (UMLS (CSP) C0597279) =Health Care Activity ;
=Patient Care;
=preadmission counseling;
|
- 33. p21 RAS Family Protein
- [Cellular protein encoded by the RAS genes. The protein has intrinsic GTPase activity and is involved in transmembrane signal transduction as a guanine nucleotide binding protein. Elevated levels of p21 c-ras have been associated with neoplasia. ( NCI )] (UMLS (NCI) C0080058) =Amino Acid, Peptide, or Protein; Enzyme
| - 83. Preadmit
- (UMLS (HL7) C0694624) =Idea or Concept =Patient Class;
|
- 34. PR
- [island in the Greater Antilles in the West Indies; a self-governing commonwealth in union with the United States. ( CSP )] (UMLS (NCI) C0034044) =Geographic Area ;
=UNITED STATES;
Caribbean | - 84. preadolescence
- [ ] (UMLS (CSP) C0598880) =Age Group ;
|
- 35. PR Domain Containing 1, with ZNF Domain Gene
- [This gene is involved in repression of transcription. It plays a role in the formation of pre-plasma memory B cells and immunoglobulin-secreting plasma cells. ( NCI )] (UMLS (NCI) C1335253) PRDM1;
PRDM1 Gene =Gene or Genome ;
| - 85. Preamendment
- (UMLS (HL7) C1548596) =Idea or Concept =Marketing basis;
|
- 36. PR Domain Containing 4 Gene
- [This gene is involved in the regulation of both transcription and cell differentiation. ( NCI )] (UMLS (NCI) C1335254) PRDM4;
PRDM4 Gene =Gene or Genome ;
| - 86. Preauricular
- (UMLS (HL7) C1550296) =Body Part, Organ, or Organ Component =Body Part;
|
- 37. Practitioner Assigned
- [A person professionally engaged medical practice who is appointed to a post or duties. ( NCI )] (UMLS (NCI) C1320721) =Professional or Occupational Group
| - 87. PREAURICULAR CYST
- [ ] (UMLS (ICD9CM) C0158599) =Disease or Syndrome ;
|
- 38. Practitioner category
- (UMLS (HL7) C1547604) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 88. Preauricular sinus or fistula
- [ ] (UMLS (ICD9CM) C0158598) =Disease or Syndrome ;
|
- 39. Practitioner group
- (UMLS (HL7) C1547752) =Professional or Occupational Group =HL7 Vocabulary Version 2.5;
| - 89. prebiotic evolution
- [ ] (UMLS (CSP) C0597986) =Functional Concept ;
|
- 40. Practitioner ID number type
- (UMLS (HL7) C1547733) =Intellectual Product =HL7 Vocabulary Version 2.5;
=County number;
Drug Enforcement Agency no.;
Medicaid number;
Medicare number;
QA number;
State license number;
Tax ID number;
Training license number;
Unique physician ID no.;
General ledger number;
Labor and industries number;
| - 90. Precancerous Atypia
- (UMLS (NCI) C1335465) Premalignant Atypia =Finding ;
|
- 41. Practitioner institutional privileges
- (UMLS (HL7) C1547380) =Idea or Concept =Data type;
| - 91. Precancerous Condition
- [A pathological process which shows signs that they can become cancerous. Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia. ( NCI )] (UMLS (NCI) C0032927) =Neoplastic Process =KASVAIMET;
=Cervix Dysplasia;
erythroplakia;
Keratotic Plaque;
AIL;
Dysmyelopoietic Syndrome;
Angioma Pigmentosum Atrophicum;
Lymphomatoid Papulosis |
- 42. Practitioner license or other ID number
- (UMLS (HL7) C1547382) =Idea or Concept =Data type;
| - 92. Precancerous Condition by Site
- (UMLS (NCI) C1335466) Premalignant Condition by Site =Disease or Syndrome ;
|
- 43. Practitioner master file
- (UMLS (HL7) C1549588) =Intellectual Product =Master file identifier code;
| - 93. precancerous dermatitis
- [A skin disease marked by scaly or thickened patches on the skin, and often caused by prolonged exposure to arsenic. The patches often occur on sunexposed areas of the skin and in older white men. These patches may become malignant (cancerous). ( NCI )] (UMLS (NCI) C1335467) =Disease or Syndrome ;
|
- 44. Practitioner Medicaid number
- (UMLS (HL7) C1549713) =Idea or Concept =Identifier type;
| - 94. Precancerous Melanosis
- (UMLS (NCI) C0334435) =Neoplastic Process
|
- 45. Practitioner Medicare number
- (UMLS (HL7) C1549715) =Idea or Concept =Identifier type;
| - 95. Precancerous Polyp
- [Growths that protrude from a mucous membrane. Precancerous polyps may (or are likely to) become cancer. ( NCI )] (UMLS (NCI) C1335468) precancerous polyps;
=Neoplastic Process ;
|
- 46. PractitionerCertifiedEntityType
- [Defines types of certifications for practitioners ( HL7V3.0 )] (UMLS (HL7) C1699451) =Intellectual Product =CertifiedEntityType;
| - 96. Precaution Code
- (UMLS (HL7) C1547814) =Intellectual Product =HL7 Vocabulary Version 2.5;
=On IV;
Aggressive;
Confused;
Deaf;
_No-code_ (i.e. Do not resuscitate);
Other;
Paraplegic;
Unknown;
Blind;
|
- 47. PractitionerGroup
- (UMLS (HL7) C1697854) =Intellectual Product =EntityCode;
| - 97. precedence effect
- [ ] (UMLS (CSP) C0599694) =Mental Process ;
|
- 48. practolol
- [A beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias. ( MSH )] (UMLS (CSP) C0032896) =Organic Chemical; Pharmacologic Substance ;
| - 98. Precentral Gyrus
- (UMLS (NCI) C0152299) =Body Part, Organ, or Organ Component
|
- 49. Prader Willi syndrome
- [congenital neurobehavioral disorder characterized by rounded face, low forehead, almond shaped eyes, squinting, hypogonadism, hypotonia, insatiable appetite leading to obesity, and mental retardation; chromosomal disorder usually associated with a deletion of the proximal portion of the long arm of chromosome 15. ( CSP )] (UMLS (CSP) C0032897) =Congenital Abnormality =Abnormalities, Multiple;
Chromosomal anomalies;
Arrieration mentale;
obesity;
syndrome;
congenital disorder;
Chromosomal Disorders, Nervous System;
| - 99. Precentral Sulcus
- (UMLS (NCI) C0228201) =Body Space or Junction
|
- 50. Prairie Band of Potawatomi Indians, Kansas
- (UMLS (HL7) C1554425) =Population Group =NativeEntityContiguous;
| - 100. precinct
- [A subsection of a municipality ( HL7V3.0 )] (UMLS (HL7) C1555559) =Idea or Concept =AddressPartType;
|
home
